Gambro (Sweden) maintains lead in world dialysis market
This article was originally published in Clinica
Gambro (Sweden) holds around 18% of the SKr 35,000 million ($5,000 million) world dialysis products market, according to the company's 1994 annual report. Renal care sales of SKr 6,389 million accounted for just over 65% of total 1994 sales of SKr 9,807 million (see Clinica No 646, p 11).
You may also be interested in...
Previous businesses FDA warned about COVID-19 claims for chlorine dioxide, a bleach solution, were marketing dietary supplements unlawfully. But Pro Breath MD's oral rinses available under the Dentist Select and OraCare brands are allowed and FDA isn’t asking the firm to discontinue distribution.
The Stark Law ban on self-referrals wouldn’t apply to some physician owners of advanced imaging facilities under a CMS final rule.
Pfizer’s abrocitinib and Biogen/Eisai’s aducanumab are among a host of new investigational products that are under review by the European Medicines Agency.